| Bioactivity | CpCDPK1/TgCDPK1-IN-1 (compound 7p) is a potent CpCDPK1/TgCDPK1 dual inhibitor (IC50: 10 nM and 5.0 nM respectively). CpCDPK1/TgCDPK1-IN-1 also inhibits Abl and Src (IC50: 75 nM and 65 nM respectively). CpCDPK1/TgCDPK1-IN-1 can be used for research of toxoplasmosis[1]. |
| Target | 10 nM and 5.0 nM (CpCDPK1/TgCDPK1) |
| Name | CpCDPK1/TgCDPK1-IN-1 |
| CAS | 1092788-23-2 |
| Formula | C18H17N5 |
| Molar Mass | 303.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wesley C. Van Voorhis, et al. Compositions And Methods For Treating Toxoplasmosis, Cryptosporidiosis, And Other Apicomplexan Protozoan Related Diseases. Patent. US20130018040. |
CpCDPK1/TgCDPK1-IN-1
CAS: 1092788-23-2 F: C18H17N5 W: 303.36
CpCDPK1/TgCDPK1-IN-1 (compound 7p) is a potent CpCDPK1/TgCDPK1 dual inhibitor (IC50: 10 nM and 5.0 nM respectively). CpC
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.